Rankings
▼
Calendar
VTYX Q1 2025 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
VTYX
Ventyx Biosciences, Inc.
$1B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$30M
Net Income
-$27M
EPS (Diluted)
$-0.39
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$253M
Total Liabilities
$22M
Stockholders' Equity
$232M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$408,000
+100.0%
Operating Income
-$30M
-$42M
+27.9%
Net Income
-$27M
-$39M
+28.9%
← Q4 2024
All Quarters
Q2 2025 →